pci-32765 and Kidney-Failure--Chronic

pci-32765 has been researched along with Kidney-Failure--Chronic* in 1 studies

Other Studies

1 other study(ies) available for pci-32765 and Kidney-Failure--Chronic

Article	Year
Ibrutinib therapy for lymphoplasmacytic lymphoma. American journal of hematology, 2017, Volume: 92, Issue:9 Topics: Adenine; Adult; Agammaglobulinaemia Tyrosine Kinase; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Immunoglobulin M; Kidney Failure, Chronic; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Proteins; Paraproteins; Piperidines; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Salvage Therapy; Treatment Outcome; Waldenstrom Macroglobulinemia	2017

Article

Year

Ibrutinib therapy for lymphoplasmacytic lymphoma.

American journal of hematology, 2017, Volume: 92, Issue:9

Topics: Adenine; Adult; Agammaglobulinaemia Tyrosine Kinase; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Immunoglobulin M; Kidney Failure, Chronic; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Proteins; Paraproteins; Piperidines; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Salvage Therapy; Treatment Outcome; Waldenstrom Macroglobulinemia

2017